Global Non-melanoma Skin Cancer Market is Expected to Register A Considerable CAGR from 2014 to 2018

Non-melanoma Skin Cancer

Non-melanoma skin cancer is one of the most common types of cancer in the world. It develops in the upper layers of the skin, but not in melanocytes. There are two types of non-melanoma skin cancer: BCC, which starts in the basal cells, and SCC, which starts in the squamous cells. BCC usually develops in the areas such as the head and neck, whereas SCC starts in the face, ears, neck, lips, and backs of the hands. These can also grow in wounds or chronic skin sores. Non-melanoma skin cancer is caused by unprotected and excessive exposure to UV radiation. It affects men more than women. It can be cured effectively if it is detected early. Treatment for non-melanoma skin cancer includes surgery, laser therapy, cryotherapy, creams, radiotherapy, chemotherapy, and PDT.

Get Sample@

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Non-melanoma Skin Cancer market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the following segments:

  • Chemotherapy, which includes drugs used in the treatment of SCC, BCC, and actinic keratosis
  • Non-invasive Treatments, which include PDT, radiotherapy, cryotherapy, and laser therapy

Global Non-melanoma Skin Cancer Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and, the EMEA and the APAC region; and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors

  • Elekta AB
  • Hoffmann-la Roche Ltd.
  • iCAD Inc.
  • Meda AB
  • Valeant Pharmaceuticals Inc.
  • Varian Medical Systems Inc.

Get 15% Discount on this Report@

Market Driver

  • Increasing Incidence of Non-melanoma Skin Cancer
  • For a full, detailed list, view our report.

Market Challenge

  • Availability of Alternative Treatments
  • For a full, detailed list, view our report.

Market Trend

  • Emergence of Combination Therapies
  • For a full, detailed list, view our report.

Check Full Report With TOC@

About Us:

Research Beam’s uniqueness lies in its highly ethical reports at economical rates because we value your relationship and growth more than money. Your growth is our aim. With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

Contact Us:

Global Head Quarters

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

phone+1 (800) 910-6452